Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review. (2022)

First Author: Andrews LJ

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/neuonc/noab247

PubMed Identifier: 34718782

Publication URI: http://europepmc.org/abstract/MED/34718782

Type: Journal Article/Review

Volume: 24

Parent Publication: Neuro-oncology

Issue: 4

ISSN: 1522-8517